Seropositive Rheumatoid Arthritis is a debilitating, systemic disease. Its symptoms go far beyond what the eye can see.

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...